vTv Therapeutics (VTVT) Reports In-Line Q3 EPS

vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Phinia to acquire stoba Group in deal expected to close in Q4 2026
• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations